The US-based e-commerce platform iHerb should follow import regulations, the Customs Administration said yesterday, after the online retailer suspended services in Taiwan due to what it called stringent customs procedures.
The agency said its customs enforcement system has remained unchanged and that iHerb should work with licensed customs brokers and courier services to have its goods cleared through customs.
iHerb, which offers more than 30,000 health and natural products, last week announced without warning that it was suspending its services in Taiwan.
It said that Taiwan’s new customs clearance processes, customs checking flows and rigorous inspections have had a major adverse effect on its time-sensitive shipments to the nation.
The company said it is working to find a solution and would resume its services in Taiwan once the issues are resolved.
However, the agency said iHerb’s complaints did not address the main issue.
The problem occurred last month, when iHerb improperly used a simplified customs declaration procedure to clear six batches of more than 10,000 products, it said, adding that the goods were intercepted at customs.
Imports of health foods and medicines must be cleared using regular customs procedures, rather than the simplified process used by some courier services, and have all related documents attached, the agency said, citing regulations.
The regulations have not been changed, and iHerb’s shipments were not intercepted because of new customs enforcement measures, it said.
The agency said that it had asked express couriers to convey the message to iHerb that Taiwan has not changed its customs regulations and that if it used licensed customs brokers that file import declarations in accordance with relevant regulations, its shipments would be cleared smoothly.
However, if the company insists on improperly declaring the goods being imported, similar incidents would likely happen again, it said.
People who buy health food or health supplements in the form of capsules and tablets from overseas for personal use are not required to apply for an import permit from the Food and Drug Administration or the customs department, the agency said.
However, the amount of such goods that can be imported for personal use is capped at 12 units (bottles, boxes, cans or bags) per item, and the total number of products in a single shipment is capped at 36 units, it said.
SHARES TUMBLE: CEO Tim Cook said that the company is not immune to challenges, ‘but we have great confidence in our teams, our products and services, and strategy’ Apple Inc said it expects supply constraints would cost US$4 billion to US$8 billion in revenue this quarter, a warning that sent the shares tumbling and cast a pall on record-setting results that the company just reported. COVID-19 pandemic restrictions that have been implemented China in the past few weeks will take a toll on the April-to-June quarter, Apple said during a conference call on Thursday. The fiscal second quarter’s sales and profit had topped analysts’ estimates, fueled by strong demand for iPhones and digital services, and the company announced US$90 billion in new stock buybacks. The outlook renewed fears that supply-chain woes
CHINA EXPOSURE: Investors are increasingly concerned over MediaTek’s exposure to a Chinese market with COVID-19 lockdowns, as well as the possibility of a price war Handset chip supplier MediaTek Inc (聯發科) yesterday posted a record net profit for last quarter and reiterated its revenue growth target of 20 percent for this year on robust demand for 5G smartphone chips from markets outside China. MediaTek has greater exposure to the Chinese market, but investors are increasingly concerned that China’s COVID-19 lockdowns are slowing its economy, and weakening demand for smartphones and computers. Investors are also concerned about a possible price war being waged by MediaTek’s rivals. “MediaTek is now in a very strong global market position backed by our leading technology and broad product portfolio, which enables us to
China’s manufacturing activity slumped to its lowest level since February 2020, official data showed on Saturday, the latest sign of economic pain as Beijing pursues its “zero COVID” strategy. The official purchasing managers’ index (PMI), a key gauge of manufacturing activity, clocked 47.4 last month — below the 50-point mark separating growth from contraction — as authorities said that a “decline in production and demand” has deepened. The figures come as Beijing’s policy of swiftly stamping out infections with lockdowns and mass testing has been severely challenged by a COVID-19 resurgence. Dozens of cities, including economic powerhouses Shenzhen and Shanghai, have been either
ASE Technology Holding Co (日月光投控) yesterday projected that revenue would grow by about 20 percent this year, more than double the semiconductor industry’s forecast growth, on the back of robust demand from the high-performance computing (HPC), networking and automotive segments. The world’s largest chip packaging and testing services provider added that the growth could continue in the next five years, as it continues to benefit from market share gains, robust customer demand and a new wave of outsourcing from integrated device manufacturers (IDMs). Taiwan Semiconductor Manufacturing Co (台積電), the world’s largest contract chipmaker and one of ASE’s major customers, recently raised the
RSS